Hui-Min Cheng Selected Research

S pombe hsp9 protein

1/2019

Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Min Cheng Research Topics

Disease

2	Fatty Liver 01/2021 - 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Insulin Resistance 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Osteoporosis 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Obesity 01/2019
1	Neoplasms (Cancer) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Atherosclerosis 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Huntington Disease (Huntington's Disease) 03/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
1	lycorineIBA 01/2021
1	ElementsIBA 01/2021
1	SterolsIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2020
1	CholesterolIBA 01/2020
1	phellodendrineIBA 05/2019
1	ChloridesIBA 05/2019
1	Fatty AlcoholsIBA 01/2019
1	LipidsIBA 01/2019
1	S pombe hsp9 proteinIBA 01/2019
1	corylinIBA 01/2019
1	polyglutamineIBA 03/2015
1	artocarpin lectinIBA 01/2015

Therapy/Procedure

1	Oral Administration 01/2019